Matica Biotechnology, Inc.

Matica Biotechnology, Inc. is a contract development and manufacturing organization (CDMO) specializing in the production of viral vectors and gene therapies. With over 15 years of experience, the company's exceptional team of industry veterans has a proven track record in delivering innovative products to the clinic and market. Matica Bio's mission is to provide a streamlined, global manufacturing solution for clients' products, utilizing state-of-the-art single-use bioreactor platforms, remote monitoring systems, quality-driven processes, and a dedicated staff. The company's unwavering focus on quality, compliance, and patient safety enables it to meet accelerated clinical approval pathways, facilitating rapid and efficient product development and manufacturing. Matica Bio aims to be a trusted partner in advancing healthcare through advanced therapies. Founded in 2019, Matica Biotechnology operates in the Biotechnology, Health Care, Manufacturing, and Pharmaceutical industries. As of now, there is no publicly available information about the company's last investment or the investors involved.